Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant chemotherapy followed by fertility-preserving conservative surgery in cervical cancer
NL-OMON46384Phase 2Active, not recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Sep 2019
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in Cervical Cancer (CC), sponsored by Netherlands Cancer Institute. Primary endpoints: Safety and feasibility of neoadjuvant chemotherapy followed by less radical surgery and Tumor reduction below 2 cm enabling conisation. Started Sep 2019; status: active, not recruiting.
02
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NL-OMON46384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46384.